Your browser doesn't support javascript.
loading
CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy.
Mayer, Sophie E; Weiss, Noel S; Chubak, Jessica; Doody, David R; Carlson, Christopher S; Makar, Karen W; Wurscher, Michelle A; Malone, Kathleen E.
  • Mayer SE; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. semayer@unc.edu.
  • Weiss NS; University of Washington, Seattle, WA, USA. semayer@unc.edu.
  • Chubak J; University of Washington, Seattle, WA, USA.
  • Doody DR; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Carlson CS; University of Washington, Seattle, WA, USA.
  • Makar KW; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Wurscher MA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Malone KE; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Cancer Causes Control ; 30(1): 103-112, 2019 Jan.
Article en En | MEDLINE | ID: mdl-30542984
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Antineoplásicos Hormonales / Citocromo P-450 CYP2D6 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Antineoplásicos Hormonales / Citocromo P-450 CYP2D6 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article